Evaluation of Clinical Efficacy and Safety of Nigella Sativa Seed Oil added to Standard Treatment in Uncomplicated Respiratory Infection - A Randomised, Open Labelled, and Parallel Arm Study

Abinaya Elango; Lakshitha Niyatee  Rao; Padmaja Sugumar; Arunkumar Radhakrishnan

Abinaya Elango Assistant Professor, Department of Pharmacology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Chengalpattu (Dt), Tamil Nadu, India.
Lakshitha Niyatee Rao Post graduate, Department of Pharmacology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Chengalpattu (Dt), Tamil Nadu, India.
Padmaja Sugumar Post graduate, Department of Pharmacology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Chengalpattu (Dt), Tamil Nadu, India.
Arunkumar Radhakrishnan Professor, Department of Pharmacology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Chengalpattu (Dt), Tamil Nadu, India.

Keywords: Nigella Sativa, Respiratory infection, RCT, Herbal treatment

Abstract

Introduction: Nigella sativa, known for its various pharmacological activities, is under trial for COVID-19.
Objectives: The objectives were to assess the efficacy of Nigella Sativa, a traditional herbal medicine, added to standard treatment in the management of uncomplicated respiratory infection in terms of reduction in severity and worsening of clinical symptoms and to assess its safety through the incidence of adverse events.

Method: The study was an open-labelled, parallel-arm, randomised controlled study in 50 participants with uncomplicated respiratory infections. Patients with symptoms of respiratory infections including fever, sore throat, throat pain, rhinitis, headache, myalgia and cough with or without expectoration for 5 days or less, were enrolled in the study. They were randomly allocated to two groups: Group 1 received standard treatment for 7 days and Group 2 Nigella Sativa oil - 1000mg twice daily with standard treatment for 7 days. The patients were physically followed up on day 4 and day 7 after starting treatment. General and systemic examination, assessment of vitals including body temperature, assessment of adverse events and clinical response to treatment were carried out during each visit.

Results: The two groups showed similar efficacy for improvement in clinical symptoms on day 7. But on day 4, more subjects became symptom-free in Group 2 (N. sativa + standard treatment) as compared to Group 1 (standard treatment alone). The incidence of adverse events was similar in both groups and all the adverse events were minor in nature.

Conclusion: Hence it is concluded that the addition of N. sativa to standard treatment could potentially benefit the patients with uncomplicated respiratory infection with early clinical cure.

How to cite this article:
Elango A, Rao LN, Sugumar P, Radhakrishnan A. Evaluation of Clinical Efficacy and Safety of Nigella Sativa Seed Oil added to Standard Treatment in Uncomplicated Respiratory Infection - A Randomised, Open Labelled, and Parallel Arm Study. Special Issue - COVID-19 & Other Communicable Disease. 2022;91-97.

DOI: https://doi.org/10.24321/0019.5138.202214

References

Younis W, Asif H, Sharif A, Riaz H, Bukhari IA, Assiri AM. Traditional medicinal plants used for respiratory disorders in Pakistan: a review of the ethno-medicinal and pharmacological evidence. Chinese Med. 2018 Dec;13(1):1-29. [PubMed] [Google Scholar]

Yimer G, Ekuadzi E, Fasinu P, de Melo AC, Pillai G. Traditional medicines for COVIDâ€19: perspectives from clinical pharmacologists. Br J ClinPharmacol. 2021 Sep;87(9):3455-8. [PubMed] [Google Scholar]

Yimer EM, Tuem KB, Karim A, Ur-Rehman N, Anwar F. Nigella sativa L. (black cumin): apromising natural remedy for wide range of illnesses. Evid Based Complement Alternat Med. 2019;2019:1528635. [PubMed] [Google Scholar]

Botnick I, Xue W, Bar E, Ibdah M, Schwartz A, Joel DM, Lev E, Fait A, Lewinsohn E. Distribution of primary and specialized metabolites in Nigella sativa seeds, a spice with vast traditional and historical uses. Molecules. 2012 Sep;17(9):10159-77. [PubMed] [Google Scholar]

Abdallah EM. Black Seed (Nigella sativa) as antimicrobial drug: a mini-review. NovelAppr Drug Design Dev. 2017;3(2):1-5. [Google Scholar]

Hasan NA, Nawahwi MZ, Malek HA. Antimicrobial activity of nigella sativa seed extract. SainsMalaysiana. 2013;42(2):143â€“7.

Chaieb K, Kouidhi B, Jrah H, Mahdouani K, Bakhrouf A. Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complement Altern Med. 2011 Dec;11(1):1-6. [PubMed] [Google Scholar]

Ansari MA, Ahmed SP, Haider S, Ansari N. Nigella sativa: anon-conventional herbal option for the management of seasonal allergic rhinitis. Pak J Pharmacol. 2006;23:31-5. [Google Scholar]

IÅŸik H, CevikbaÅŸ A, GÃ¼rer US, Kiran B, Uresin Y, Rayaman P, Rayaman E, GÃ¼rbÃ¼z B, BÃ¼yÃ¼kÃ¶ztÃ¼rk S. Potential adjuvant effects of Nigella sativa seeds to improve specific immunotherapy in allergic rhinitis patients. Med PrincPract. 2010;19(3):206-11. [PubMed] [Google Scholar]

Arunkumar R, Maignanakumar R, Duraivel M, Ahamedbasha A, Ruckmani A. A single centre, prospective, randomized, open labelled clinical study to evaluate the effectiveness of Siddha Poly Herbal Formulation, Viprotm, towards the management of uncomplicated respiratory infection. Biomed Pharmacol J.2021;14(2):793-802. [Google Scholar]